Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be “completely different” than those being developed by MiniMed and Tandem Diabetes ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...

Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...

Hospitalized patients with complex dietary restrictions often develop hyperglycemia, or high blood sugar. This occurs in roughly one-quarter to one-half of these patients and can lead to serious ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic turning point. The company confirms its status as a global reference partner for ...

A new therapy for type 1 diabetes could nix the need for insulin injections. Just a single infusion of lab-grown pancreatic cells let patients’ bodies make all the insulin they needed, scientists ...

Leo, a 22-year-old man who received a diagnosis of type 1 diabetes at 17 years of age, has struggled to meet glucose targets. As a young adult, he has many competing priorities, and diabetes is not ...

Share on Pinterest Mounjaro appears to be a safe and effective adjunct therapy to slow-release insulin for treating uncontrolled diabetes. Mohammed Al Ali/Shutterstock Tirzepatide, Mounjaro, is ...

MiniMed MMED recently announced the commercial launch of its MiniMed 780G automated insulin delivery system integrated with Abbott Laboratories' ABT Instinct sensor and the MiniMed Go system ...

A Vertex Pharmaceuticals cell therapy for type 1 diabetes is enabling patients to produce insulin, eliminating the need for additional insulin therapy in the vast majority of participants in a key ...